Yacong He

Dr. Yacong He


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in Phytotherapy Research
Verified
Journal Article
Closed access
YWYilan Wang
Yilan Wang
SZSijing Zhao
Sijing Zhao
NJNan Jia
Nan Jia
ZSZherui Shen
Zherui Shen
DHDemei Huang
Demei Huang
ZWZhen-Xing Wang
Zhen-Xing Wang


9 March 2023 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
DHDemei Huang
Demei Huang
ZSZherui Shen
Zherui Shen
SZSijing Zhao
Sijing Zhao
CPCaixia Pei
Caixia Pei
NJNan Jia
Nan Jia
MLMing Lei
Ming Lei

21 May 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YWYilan Wang
Yilan Wang
YYYongjun Yin
Yongjun Yin
YLYing Liu
Ying Liu
CPCaixia Pei
Caixia Pei
ZSZherui Shen
Zherui Shen
ZWZhen-Xing Wang
Zhen-Xing Wang
High-altitude myocardial injury (HAMI) represents a critical form of altitude illness for which effective drug therapies are generally lacking. Notoginsenoside R1, a prominent constituent derived from Panax notoginseng, has demonstrated various cardioprotective properties in models of myocardial ischemia/reperfusion injury, sepsis-induced cardiomyopathy, cardiac fibrosis, and myocardial injury. The potential utility of notoginsenoside R1 in the management of HAMI warrants prompt investigation. Following the successful construction of a HAMI model, a series of experimental analyses were conducted to assess the effects of notoginsenoside R1 at dosages of 50 mg/Kg and 100 mg/Kg. The results indicated that notoginsenoside R1 exhibited protective effects against hypoxic injury by reducing levels of CK, CK-MB, LDH, and BNP, leading to improved cardiac function and decreased incidence of arrhythmias. Furthermore, notoginsenoside R1 was found to enhance Nrf2 nuclear translocation, subsequently regulating the SLC7A11/GPX4/HO-1 pathway and iron metabolism to mitigate ferroptosis, thereby mitigating cardiac inflammation and oxidative stress induced by high-altitude conditions. In addition, the application of ML385 has confirmed the involvement of Nrf2 nuclear translocation in the therapeutic approach to HAMI. Collectively, the advantageous impacts of notoginsenoside R1 on HAMI have been linked to the suppression of ferroptosis via Nrf2 nuclear translocation signaling.


28 September 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ZSZherui Shen
Zherui Shen
DHDemei Huang
Demei Huang
NJNan Jia
Nan Jia
SZSijing Zhao
Sijing Zhao
CPCaixia Pei
Caixia Pei
ZWZhen-Xing Wang
Zhen-Xing Wang
Eleutheroside E (EE) is a primary active component of Acanthopanax senticosus, which has been reported to inhibit the expression of inflammatory genes, but the underlying mechanisms remain elusive. High-altitude pulmonary edema (HAPE) is a severe complication of high-altitude exposure occurring after ascent above 2500 m. However, effective and safe preventative measures for HAPE still need to be improved. This study aimed to elucidate the preventative potential and underlying mechanism of EE in HAPE. Rat models of HAPE were established through hypobaric hypoxia. Mechanistically, hypobaric hypoxia aggravates oxidative stress and upregulates (pro)-inflammatory cytokines, activating NOD-like receptor protein 3 (NLRP3) inflammasome-mediated pyroptosis, eventually leading to HAPE. EE suppressed NLRP3 inflammasome-mediated pyroptosis by inhibiting the nuclear translocation of nuclear factor kappa-Β (NF-κB), thereby protecting the lung from HAPE. However, nigericin (Nig), an NLRP3 activator, partially abolished the protective effects of EE. These findings suggest EE is a promising agent for preventing HAPE induced by NLRP3 inflammasome-mediated pyroptosis.